MarketInOut Stock Screener Log In | Sign Up
 

Revvity Inc

NYSE • Healthcare • Diagnostics & Research • Quote as of 10/23/2026
Revvity Inc stock price and volume chart

Company Profile

IndustryDiagnostics & Research
SectorHealthcare
ExchangeNYSE
Market Capitalization17,559 mln
Float111 mln
Earnings Date11/03/2026

EPS

2.09
Stretched

P / E

75.97
Speculative

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-2.54
Likely reliable

1-Year Forecast

147.53
Limited downside

Relative Strength

77 / 100
Strongly outperforming

Business Description

Revvity Inc., formerly PerkinElmer, is a health sciences company founded in 1937 and based in Waltham, Massachusetts. It provides tools, software, and services that help detect and diagnose a wide range of conditions, from genetic disorders like Down syndrome and muscular dystrophy to infectious diseases, serving everyone from hospitals and research labs to government agencies. The company also supports advanced scientific work in areas such as cancer research, drug discovery, and DNA analysis.

Key Fundamentals

EPS2.09
P/E75.97
ROE3.25
RPS25.77
ROIC3.83
ROA1.96
Interest Cover4.79
EBITDA, mln767
EV / EBITDA25.72
EV / EBIT55.61
Revenue, mln2,912
EV / Revenue6.78

Quote Details

Last 158.77
Change 1.48 (0.94%)
Open 156.35
Volume 1,113,334
Turnover 176,764,048
Average Volume 1,810,127

Financial Ratios

Pre-Tax Profit Margin9
Leverage Ratio1.67
Current Ratio1.80
Price / Book2.41
Price / Cash Flow27.96
Price / Free Cash Flow31.58
Debt / Equity0.46
Price / Sales6.04
PEG Ratio0.73

Financial Strength

Altman Z-Score3.28
Piotroski F-Score 6 / 9
Beneish M-Score-2.54
Price to Intrinsic Value1.45
1-Year Target Price147.53
Shiller PE Ratio36.19
Short Ratio2.78
Short % of Float8.46

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 4.06% 90 / 100   
1 Month 5.42% 84 / 100   
2 Months 49.23% 99 / 100   
6 Months 83.17% 99 / 100   
1 Year 66.36% 96 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog